![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 2-(2-(oxazol-2-yl)-5-(4-(4-((propan-2-yl)oxy)benzenesulfonyl(piperazin-1-yl)phenoxy)acetic Acid
2. Bge 175
3. Bge-175
4. S-555739
1. 932372-01-5
2. Asapiprant [inn]
3. Bge-175
4. B2lw71crgl
5. S-555739
6. Bge175
7. 2-(5-(4-((4-isopropoxyphenyl)sulfonyl)piperazin-1-yl)-2-(oxazol-2-yl)phenoxy)acetic Acid
8. 2-(2-(oxazol-2-yl)-5-(4-(4-((propan-2-yl)oxy)benzenesulfonyl(piperazin-1-yl)phenoxy)acetic Acid
9. Acetic Acid, 2-(5-(4-((4-(1-methylethoxy)phenyl)sulfonyl)-1-piperazinyl)-2-(2-oxazolyl)phenoxy)-
10. Unii-b2lw71crgl
11. Bge175 [who-dd]
12. Schembl1106973
13. Chembl3545043
14. Gtpl11951
15. Bcp30346
16. Ex-a2993
17. Zb1516
18. Akos037515672
19. Cs-8174
20. Sb19848
21. Example Ii-74 [us8153793b2]
22. 2-[2-(1,3-oxazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]acetic Acid
23. Ac-36280
24. Bs-17884
25. Hy-16763
26. A16983
27. D80655
28. S-555739; Cs-2811
29. Q27274281
30. S-555739; S 555739; S555739
Molecular Weight | 501.6 g/mol |
---|---|
Molecular Formula | C24H27N3O7S |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Exact Mass | 501.15697138 g/mol |
Monoisotopic Mass | 501.15697138 g/mol |
Topological Polar Surface Area | 131 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 789 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |